Frazier Life Sciences
Palo Alto, Californiafrazierls.com
Overview
Frazier Life Sciences is a healthcare investment firm that invests globally in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| RQ Biotechnology Limited | Jun 2026 | Series A | Lead |
| cAMPfield Therapeutics | Jun 2026 | Series A | Lead |
| cAMPfield Therapeutics | May 2026 | Series A | Co-investor |
| Sidewinder | Apr 2026 | Series B | Lead |
| Sidewinder Therapeutics | Apr 2026 | Series B | Lead |
Key People
Patrick Heron
Managing Partner
Daniel Estes
General Partner
Jamie B.
General Partner And Portfolio Manager
Adam Simpson
Venture Partner
Aditya Kohli
Venture Partner
James Li
Venture Partner
Mitchell Gold
Venture Partner
Stanford Peng
Venture Partner
Tao Fu
Venture Partner
Jennifer Martin
Chief Financial Officer and Partner
Ailsa Dalgliesh
Head Of Investor Relations
Anna H. Chen
Principal
Chris Aakre
Principal Of Company Creation
Lauren Mifflin
Principal, Company Creation
Gordon Empey
Partner & General Counsel
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
